BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17966039)

  • 1. Down-regulation of Fas-ligand mRNA in Sjögren's syndrome patients with enlarged exocrine glands.
    Tsuzaka K; Matsumoto Y; Sasaki Y; Abe T; Tsubota K; Takeuchi T
    Autoimmunity; 2007 Nov; 40(7):497-502. PubMed ID: 17966039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mikulicz's disease and Sjögren's syndrome.
    Tsubota K; Fujita H; Tsuzaka K; Takeuchi T
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1666-73. PubMed ID: 10845583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
    Zhou W; Dong Y; Zhao Y; Tang FL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
    Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
    Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjögren's syndrome.
    Wakamatsu E; Matsumoto I; Yasukochi T; Naito Y; Goto D; Mamura M; Ito S; Tsutsumi A; Sumida T
    Arthritis Rheum; 2006 Nov; 54(11):3476-84. PubMed ID: 17075845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome.
    Bachmann M; Hilker M; Grölz D; Tellmann G; Hake U; Kater L; de Wilde P; Tröster H
    J Autoimmun; 1996 Dec; 9(6):757-66. PubMed ID: 9115578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.
    Bolstad AI; Wargelius A; Nakken B; Haga HJ; Jonsson R
    J Rheumatol; 2000 Oct; 27(10):2397-405. PubMed ID: 11036836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas ligand expression in TM4 Sertoli cells is enhanced by estradiol "in situ" production.
    Catalano S; Rizza P; Gu G; Barone I; Giordano C; Marsico S; Casaburi I; Middea E; Lanzino M; Pellegrino M; Andò S
    J Cell Physiol; 2007 May; 211(2):448-56. PubMed ID: 17167783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
    Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
    Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nourishing Yin, strengthening Qi and activating blood decoction on Fas/FasL in salivary glands of NOD mice with Sjogren's syndrome and their mRNA expression].
    Wu GL; Li TY; Lu WW; Yu GY; Fan YS
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4148-51. PubMed ID: 24791507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands.
    Tsubota K; Fujita H; Tadano K; Onoda N; Tsuzaka K; Takeuchi T
    Clin Exp Immunol; 2002 Jul; 129(1):177-82. PubMed ID: 12100038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome.
    Sumida T; Matsumoto I; Murata H; Namekawa T; Matsumura R; Tomioka H; Iwamoto I; Saito Y; Mizushima Y; Hasunuma T; Maeda T; Nishioka K
    J Immunol; 1997 Jan; 158(2):1020-5. PubMed ID: 8993025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.
    Masaki Y; Dong L; Kurose N; Kitagawa K; Morikawa Y; Yamamoto M; Takahashi H; Shinomura Y; Imai K; Saeki T; Azumi A; Nakada S; Sugiyama E; Matsui S; Origuchi T; Nishiyama S; Nishimori I; Nojima T; Yamada K; Kawano M; Zen Y; Kaneko M; Miyazaki K; Tsubota K; Eguchi K; Tomoda K; Sawaki T; Kawanami T; Tanaka M; Fukushima T; Sugai S; Umehara H
    Ann Rheum Dis; 2009 Aug; 68(8):1310-5. PubMed ID: 18701557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
    Tsubota K; Nishiyama T; Mishima K; Inoue H; Doi T; Hattori Y; Kodama T; Higuchi A; Hayashi Y; Saito I
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4753-60. PubMed ID: 19407023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome.
    Ogawa N; Kawanami T; Shimoyama K; Ping L; Sugai S
    Clin Immunol; 2004 Sep; 112(3):235-8. PubMed ID: 15308116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
    Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
    Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.
    Saito I; Haruta K; Shimuta M; Inoue H; Sakurai H; Yamada K; Ishimaru N; Higashiyama H; Sumida T; Ishida H; Suda T; Noda T; Hayashi Y; Tsubota K
    J Immunol; 1999 Mar; 162(5):2488-94. PubMed ID: 10072487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.
    Bolstad AI; Eiken HG; Rosenlund B; Alarcón-Riquelme ME; Jonsson R
    Arthritis Rheum; 2003 Jan; 48(1):174-85. PubMed ID: 12528117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.